In contrast, granule cells in FTLD-TDP, ALS, and AD patients typically exhibited multiple RBM45 nuclear inclusions with a corresponding loss of nuclear/perinucleolar RBM45 immunoreactivity (Fig. 7b-d, respectively). The gene discussed is RBM45; the disease is Alzheimer disease.